Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

Virus
August 2, 2018/Cancer/Research

Case Series: Patients with Unresectable Melanoma Respond to New Combination Treatment

Outcomes hold promise for future RCT results

20496714399_9d12e253e1_z_650x450
July 31, 2018/Cancer/Research

Investigating Melanoma’s Molecular Driver Mutation Signature

Impact on tumor immune microenvironment and response to immunotherapy

nci-vol_650x450
July 27, 2018/Cancer/News & Insight

A One-Day Melanoma Refresh with Cleveland Clinic Experts

Complimentary case-based program Aug. 24

18-ENT-911-Joshi-Hero-Image-50x450pxl
July 26, 2018/Cancer

Salvage Surgery and Reirradiation with Chemotherapy for Recurrent Head and Neck Cancers

A multidisciplinary approach is necessary

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

RP-Sarcoma-650×450

Unique Strategies Target Retroperitoneal Sarcomas

An exacting emphasis on precision approaches

nci multiple myeloma
July 12, 2018/Cancer/Research

New Ibrunitib Combo a Powerful Combatant Against Relapsed/Refractory Multiple Myeloma

Encouraging results for an incurable bone cancer

nci-vol-11238_650x450
July 10, 2018/Cancer/Research

Making Heads or Tails of Adjunctive Therapy in Pancreatic Cancers

Does tumor location matter?

cytokine_650x450
July 9, 2018/Cancer/Research

ALT-803 + Nivolumab Found Safe, Effective in Metastatic NSCLC

An IL-15 superagonist shows promise

Dermatologist examining patient
July 5, 2018/Cancer/News & Insight

Progress in Melanoma Treatment Development Improves Prognosis for Advanced Disease

New adjuvant therapies, advances in neoadjuvant

Researcher in lab

Prostate Cancer Drug Metabolite May Fuel Cancer Cells

Men with the HSD3B1(1245C) variant metabolize abiraterone differently

BackPage 76 of 88Next

Advertisement

Ad